Clinical Trials on Steroid-Refractory Acute Graft Versus Host Disease in Canada
Total 167 results
-
MaaT PharmaRecruitingAcute Graft Versus Host Disease in Intestine | Steroid Refractory GVHDSpain, France, Germany, Austria, Belgium, Italy
-
Lee DupuisC17 CouncilCompletedAcute-graft-versus-host DiseaseCanada
-
Genentech, Inc.TerminatedAcute Graft-versus-host DiseaseUnited States, Canada
-
Jazz PharmaceuticalsCompletedAcute-graft-versus-host Disease | Graft-versus-host DiseaseUnited States, Belgium, United Kingdom, Greece, Germany, Spain, France, Italy, Austria, Canada, Bulgaria, Croatia, Poland, Portugal
-
MallinckrodtPRA Health SciencesTerminatedAcute Graft-versus-Host DiseaseUnited States, Canada, Germany, United Kingdom, Australia, Austria, Belgium, Italy, France, Netherlands, Switzerland
-
Fundación Pública Andaluza para la gestión de la...Instituto de Salud Carlos IIIActive, not recruitingGraft-versus-host DiseaseSpain
-
EquilliumBiocon LimitedRecruitingGraft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHDUnited States, Korea, Republic of, Germany, Israel, Spain, Belgium, Italy, Australia, France, Canada, Portugal, New Zealand
-
Novartis PharmaceuticalsCompletedAcute Graft Versus Host DiseaseBelgium, Japan, Spain, France, Korea, Republic of, Canada, Italy, Denmark
-
Novartis PharmaceuticalsCompletedCorticosteroid Refractory Acute Graft vs Host DiseaseGermany, Japan, Saudi Arabia, Turkey, United Kingdom, Spain, Canada, Italy, Australia, Austria, France, Korea, Republic of, Hong Kong, Israel, Netherlands, Russian Federation, Denmark, Greece, Taiwan, Norway, Czechia, Bulgaria
-
Mesoblast, Inc.CompletedGraft Versus Host DiseaseUnited States, Australia, Canada
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
Mesoblast, Inc.CompletedGraft Versus Host DiseaseUnited States, Italy, Australia, Canada, Switzerland, United Kingdom
-
AHS Cancer Control AlbertaRecruitingRelapse | Graft-versus-host-diseaseCanada
-
Millennium Pharmaceuticals, Inc.CompletedHematopoietic Stem CellsUnited States, Spain, Taiwan, Australia, Canada, Singapore, Korea, Republic of, Mexico, Switzerland, Japan, Germany, Norway, Israel, Russian Federation, Hungary, United Kingdom, Italy, Romania, Brazil, France, Austria, Belgium, Port... and more
-
University Health Network, TorontoHoffmann-La RocheTerminatedGraft Versus Host DiseaseCanada
-
McMaster UniversitySanofi; Ozmosis Research Inc.; Cell Therapy Transplant CanadaRecruitingAcute Leukemia | Myelodysplasia | Chronic Graft-versus-host-diseaseCanada, Australia
-
Andalusian Initiative for Advanced Therapies -...Iniciativa Andaluza en Terapias AvanzadasCompletedImmune System Diseases | Graft Versus Host Disease | Chronic and Expanded Graft Versus Host DiseaseSpain
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Leukemia | Hematopoietic and Lymphoid System NeoplasmUnited States, Canada
-
Gilead SciencesTerminatedChronic Graft Versus Host DiseaseSpain, Korea, Republic of, United States, Germany, Canada, France, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States, Canada, Australia, Switzerland, Puerto Rico, New Zealand
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Graft Versus Host DiseaseUnited States, Australia, Austria, Canada, China, Croatia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Singapore, Spain, Taiwan
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)Belgium, Italy, Spain, Saudi Arabia, Turkey, United Kingdom, Germany, Greece, Canada, Austria, France, Israel, Netherlands, Sweden, Switzerland, Korea, Republic of, Bulgaria, Japan, Norway, Czechia, Russian Federation, Jordan, Hungary, Ind... and more
-
University Health Network, TorontoBayerCompletedAlemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell TransplantsBone Marrow Transplantation | Graft Versus Host DiseaseCanada
-
University Health Network, TorontoCompletedMyelodysplastic/Myeloproliferative Neoplasm | Allogeneic Hematopoietic Cell Transplant | Steroid Refractory GVHDCanada
-
Mesoblast, Inc.No longer availableGraft vs Host Disease | Graft-Versus-Host DiseaseUnited States, Canada
-
John LevineRecruitingAdverse Effects | Acute Graft vs Host Disease | Allogeneic Bone Marrow TransplantationUnited States, Canada
-
University of CalgaryAlberta Health services; University of AlbertaTerminated
-
University Health Network, TorontoActive, not recruiting
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseKorea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
-
Incyte CorporationTerminatedChronic Graft-versus-host DiseaseUnited States, Spain, France, Canada, Israel, United Kingdom, Germany, Italy, Denmark, Sweden, Finland, Belgium, Poland, Greece, Austria, Switzerland
-
Stanford UniversityNovartisCompletedLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Peripheral | Bone Marrow Transplant FailureUnited States, Canada
-
University of British ColumbiaActive, not recruitingChronic Graft vs Host DiseaseCanada, United States, Austria
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous Leukemia (AML) | Acute Lymphocytic Leukemia (ALL) | Graft vs. Host Disease (GvHD)United States, Canada
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Graft Versus Host DiseaseUnited States, Canada
-
Martin, PaulNational Cancer Institute (NCI)TerminatedCancerUnited States, Canada
-
Incyte CorporationActive, not recruitingChronic Graft Versus Host Disease | Myelofibrosis | Postlung Transplant (Bronchiolitis Obliterans)United States, Spain, Italy, Germany, Belgium, Austria, Israel, Canada, Greece
-
European Society for Blood and Marrow TransplantationMallinckrodtCompletedSteroid Refractory GVHDSpain, United Kingdom, Sweden, Italy, Israel, France, Denmark, Germany, Poland, Turkey, Romania, Belgium, Greece, Russian Federation
-
University of British ColumbiaRecruitingLeukemia | Allogeneic Hematopoietic Stem Cell Transplantation | Blood Cancer | Chronic Graft-versus-Host-Disease | Non-Malignant Hematologic and Lymphocytic DisorderUnited States, Canada
-
Pharmacyclics LLC.Janssen Research & Development, LLCActive, not recruitingChronic Graft Versus Host DiseaseUnited States, Spain, Korea, Republic of, Australia, Austria, Canada, France, Germany, Israel, Italy, Netherlands, Russian Federation, United Kingdom
-
SanofiRecruitingChronic Graft Versus Host DiseaseAustralia, Argentina, Belgium, Spain, Sweden, Czechia, United Kingdom, United States, Italy, Germany, Canada, Israel, Denmark, Brazil
-
University of British ColumbiaRecruitingLeukemia | Allogeneic Hematopoietic Stem Cell Transplantation | Blood Cancer | Chronic Graft-versus-Host-Disease | Non-Malignant Hematologic and Lymphocytic DisorderUnited States, Canada
-
Novartis PharmaceuticalsActive, not recruitingGraft vs Host DiseaseJapan, Slovakia, Taiwan, Spain, Korea, Republic of, Thailand, Canada, Russian Federation, Italy, Turkey, India, Czechia, Brazil, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Lymphoblastic Leukemia in Remission | Graft Versus Host Disease | B-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia
-
Kiadis PharmaCompletedGraft vs Host DiseaseCanada
-
National Cancer Institute (NCI)Recruiting
-
Boston Children's HospitalFDA Office of Orphan Products DevelopmentActive, not recruiting
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedKidney Transplantation | Graft vs Host DiseaseCanada, United States
-
University of British ColumbiaAstellas Pharma Canada, Inc.CompletedDiabetes | Acute Graft RejectionCanada
-
University of CalgaryCompletedPleural Effusions Post Coronary Artery Bypass GraftCanada
-
University Health Network, TorontoRecruitingLong COVID | Post Acute Sequelae of COVID-19 | Post COVID ConditionCanada